| 000 | 01220nam a22001697a 4500 | ||
|---|---|---|---|
| 008 | 190330b2017 xxu||||| |||| 00| 0 eng d | ||
| 020 | _a9781118662311 | ||
| 082 | _a616.0798 LIU-C | ||
| 100 | _aedited by Liu, Cheng | ||
| 245 |
_aBiosimilars of monoclonal antibodies : _ba practical guide to manufacturing, preclinical, and clinical development / _cedited by Cheng Liu and K. John Morrow |
||
| 260 |
_aNew Jersey _bWiley _c2017 |
||
| 300 | _a652 p. | ||
| 365 |
_aUSD _b194.95. |
||
| 500 | _aAddressing a significant need by describing the science and process involved to develop biosimilars of monoclonal antibody (mAb) drugs, this book covers all aspects of biosimilar development: preclinical, clinical, regulatory, manufacturing. Guides readers through the complex landscape involved with developing biosimilar versions of monoclonal antibody (mAb) drugs Features flow charts, tables, and figures that clearly illustrate processes and makes the book comprehensible and accessible Includes a review of FDA-approved mAb drugs as a quick reference to facts and useful information Examines new technologies and strategies for improving biosimilar mAbs | ||
| 650 | _aMonoclonal antibodies | ||
| 700 | _aMorrow, K. John | ||
| 999 |
_c39386 _d39386 |
||